Neurol. praxi. 2017;18(3):156-160 | DOI: 10.36290/neu.2017.022

Episodic dizziness and vertigo

doc. MUDr. Štefan Sivák, PhD.
Neurologická klinika JLF UK a UN, Martin

Episodic dizziness/vertigo or episodic vestibular syndrome is characterized by recurrent attacks of dizziness/vertigo with a duration

of several seconds, minutes, or even hours, with periods of remission. It is a common problem in patients. Episodic dizziness/

vertigo can occur due to a variety of causes, including vestibular or primarily nonvestibular, peripheral or central, benign as well

as life-threatening ones. Patients usually present in a period between the attacks; therefore, the correct diagnosis is based on a

thorough history with an emphasis on temporal characteristics of the dizziness/vertigo, the presence of precipitating causes and

associated nonvestibular symptoms. The differential diagnosis is broad.

Keywords: episodic dizziness, episodic vertigo, episodic vestibular syndrome, differential diagnosis

Received: April 18, 2017; Accepted: May 27, 2017; Published: July 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sivák Š. Episodic dizziness and vertigo. Neurol. praxi. 2017;18(3):156-160. doi: 10.36290/neu.2017.022.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bisdorff A. Chapter 6 - vestibular symptoms and history taking. In: Handbook of Clinical Neurology. Elsevier 2016; (137): 83-90. Go to original source... Go to PubMed...
    2. Bisdorff A, Von Brevern M, Lempert T, Newman-Toker DE. Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vestib Res 2009; 19(1-2): 1-13. Go to original source... Go to PubMed...
    3. Bovo R, Ciorba A, Martini A. The diagnosis of autoimmune inner ear disease: evidence and critical pitfalls. Eur Arch Otorhinolaryngol 2009; 266(1): 37-40. Go to original source... Go to PubMed...
    4. Brandt T, Strupp M, Dieterich M. Vestibular paroxysmia: a treatable neurovascular cross-compression syndrome. J Neurol 2016; 263(Suppl 1): S90-6. Go to original source... Go to PubMed...
    5. Buniel MC, Geelan-Hansen K, Weber PC, Tuohy VK. Immunosuppressive therapy for autoimmune inner ear disease. Immunotherapy 2009; 1(3): 425-434. Go to original source... Go to PubMed...
    6. Choi KD, Choi JH. Episodic ataxias: clinical and genetic features. J Mov Disord 2016; 9(3): 129-135. Go to original source... Go to PubMed...
    7. Dieterich M, Obermann M, Celebisoy N. Vestibular migraine: the most frequent entity of episodic vertigo. J Neurol 2016; 263(Suppl. 1): S82-9. Go to original source... Go to PubMed...
    8. Dvorák M, Hlubeková A, Carter K, Šimo M. Cervikálne vertigo. Neurol. prax 2009; 10(5): 296-301.
    9. Edlow JA. Diagnosing dizziness: we are teaching the wrong paradigm! Acad Emerg Med 2013; 20(10): 1064-1066. Go to original source... Go to PubMed...
    10. Espinosa-Sanchez JM, Lopez-Escamez JA. Meni?re's disease. Handb Clin Neurol 2016; 137: 257-277. Go to original source... Go to PubMed...
    11. Hahn A. Otoneurologie a tinitologie. Grada; 2015.
    12. Ho ML, Moonis G, Halpin CF, Curtin HD. Spectrum of third window abnormalities: semicircular canal dehiscence and beyond. AJNR Am J Neuroradiol 2017; 38(1): 2-9. Go to original source... Go to PubMed...
    13. Jeřábek J. Diagnostika pacienta s akutní závratí. Cesk Slov Neurol N 2015; 78/111(5): 503-510. Go to original source...
    14. Jeřábek J. Vestibula?rni? a okulomotoricke? poruchy u pacientu? s roztrous?enou sklero?zou. Neurol. praxi 2016; 17(3): 163-168. Go to original source...
    15. Jung I, Kim JS. Approach to dizziness in the emergency department. Clin Exp Emerg Med 2015; 2(2): 75-88. Go to original source... Go to PubMed...
    16. Kim SH, Park SH, Kim HJ, Kim JS. Isolated central vestibular syndrome. Ann N Y Acad Sci 2015; 1343: 80-89. Go to original source... Go to PubMed...
    17. Klaas JP, Burkholder DB, Singer W, Boes CJ. Harry Lee Parker and paroxysmal dysarthria and ataxia. Neurology 2013; 80(3): 311-314. Go to original source... Go to PubMed...
    18. Kremmyda O, Zwergal A, la Foug?re C, Brandt T, Jahn K, Strupp M. 4-Aminopyridine suppresses positional nystagmus caused by cerebellar vermis lesion. J Neurol 2013; 260(1): 321-323. Go to original source... Go to PubMed...
    19. Mitro P. Etiológia a patogenéza synkopálnych stavov. In: Synkopa. Equilibria; 2008.
    20. Murdin L, Schilder AG. Epidemiology of balance symptoms and disorders in the community: a systematic review. Otol Neurotol 2015; 36(3): 387-392. Go to original source... Go to PubMed...
    21. Neuhauser HK, von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, Lempert T. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology 2005; 65(6): 898-904. Go to original source... Go to PubMed...
    22. Newman-Toker DE, Edlow JA. TiTrATE: A Novel, Evidence-Based approach to diagnosing acute dizziness and vertigo. Neurol Clin 2015; 33(3): 577-599. Go to original source... Go to PubMed...
    23. Tarnutzer AA, Lee SH, Robinson KA, Kaplan PW, Newman-Toker DE. Clinical and electrographic findings in epileptic vertigo and dizziness: a systematic review. Neurology 2015; 84(15): 1595-1604. Go to original source... Go to PubMed...
    24. von Brevern M, Bertholon P, Brandt T, Fife T, Imai T, Nuti D, Newman-Toker D. Benign paroxysmal positional vertigo: Diagnostic criteria. J Vestib Res 2015; 25(3-4): 105-117. Go to original source... Go to PubMed...
    25. Vyhnálek M, Brzezny R, Jeřábek J. Benigní paroxysmalní polohové vertigo - nejčastější závratě v lekářské ordinaci. Neurol. praxi 2007; (8)6: 348-350.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.